Terumo Corp (OTCPK:TRUMF)
$ 20.306 1.844 (9.99%) Market Cap: 32.01 Bil Enterprise Value: 29.11 Bil PE Ratio: 38.46 PB Ratio: 3.58 GF Score: 97/100

Q3 2024 Terumo Corp Earnings Presentation Transcript

Feb 07, 2024 / 08:00AM GMT
Release Date Price: $17.94 (+4.04%)

Feb 07, 2024 / 08:00AM GMT
Presentation
Feb 07, 2024 / 08:00AM GMT

=====================
Corporate Participants
=====================
* Antoinette L. Gawin
Terumo Corporation - Group Managing Executive Officer and President of Blood & Cell Technologies Company
* Naoki Muto
Terumo Corporation - Chief Accounting & Financial Officer and Group Executive Officer

=====================
Conference Call Participants
=====================
* Hidemaru Yamaguchi
Citigroup Inc., Research Division - Research Analyst
* Motoya Kohtani
Mizuho Securities Co., Ltd., Research Division - Senior Analyst
* Ryotaro Hayashi
Morgan Stanley, Research Division - Equity Analyst
* Shinnosuke Tokumoto
SMBC Nikko Securities Inc., Research Division - Analyst
* Stephen Barker
Jefferies LLC, Research Division - Equity Analyst
* Takahiro Mori
Nomura Securities Co. Ltd., Research Division - Research Analyst
* Takashi Akahane
Tokai Tokyo Research Institute Co., Ltd. - Senior Analyst
* Tomoko

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot